Search by Drug Name or NDC
NDC 16571-0824-10 Meclizine HCl 25 mg/1 Details
Meclizine HCl 25 mg/1
Meclizine HCl is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Rising Pharmaceuticals, Inc.. The primary component is MECLIZINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
Related Packages: 16571-0824-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Meclizine
Product Information
NDC | 16571-0824 |
---|---|
Product ID | 16571-824_448cc004-c7a5-42b0-9a2e-79790e66baa8 |
Associated GPIs | |
GCN Sequence Number | 004736 |
GCN Sequence Number Description | meclizine HCl TAB CHEW 25 MG ORAL |
HIC3 | H6J |
HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
GCN | 18312 |
HICL Sequence Number | 001975 |
HICL Sequence Number Description | MECLIZINE HCL |
Brand/Generic | Generic |
Proprietary Name | Meclizine HCl |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | MECLIZINE HYDROCHLORIDE CHEWABLE |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, CHEWABLE |
Route | ORAL |
Active Ingredient Strength | 25 |
Active Ingredient Units | mg/1 |
Substance Name | MECLIZINE HYDROCHLORIDE |
Labeler Name | Rising Pharmaceuticals, Inc. |
Pharmaceutical Class | Antiemetic [EPC], Emesis Suppression [PE] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part336 |
Listing Certified Through | 2024-12-31 |
Package
Package Images


NDC 16571-0824-10 (16571082410)
NDC Package Code | 16571-824-10 |
---|---|
Billing NDC | 16571082410 |
Package | 1000 TABLET, CHEWABLE in 1 BOTTLE (16571-824-10) |
Marketing Start Date | 2022-08-18 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.03227 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | MECLIZINE 25 MG TABLET CHEW |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL 6ab6cf0e-a6c9-4b5a-95c1-37c279bf18dc Details
Warnings
SPL UNCLASSIFIED SECTION
When using this product
Keep out of reach of children.
Directions
Other Information
Inactive ingredients
TAMPER EVIDENT: DO NOT USE IF FOIL SEAL UNDER CAP, PRINTED WITH"SEALED for YOUR PROTECTION" IS BROKEN OR MISSING.Rising Pharma Holdings, Inc. is not affiliated with the owner of the registered trademark Bonine® Manufactured by: Unique Pharmaceutical Laboratories(A Div. of J.B. Chemicals & Pharmaceuticals Ltd.),Mumbai 400 030, India Distributed by: Rising Pharma Holdings, Inc.East Brunswick, NJ 08816 Mfg. Lic. No.: G/1430Feb 2022
PRINCIPAL DISPLAY PANEL - 25 mg Chewable Tablet Label
INGREDIENTS AND APPEARANCE
MECLIZINE HCL
meclizine hydrochloride chewable tablet, chewable |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
Labeler - Rising Pharmaceuticals, Inc. (835513529) |
Registrant - Unique Pharmaceutical Laboratories (917165052) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Unique Pharmaceutical Laboratories | 650434645 | manufacture(16571-824) |
Revised: 8/2022
Document Id: 448cc004-c7a5-42b0-9a2e-79790e66baa8
Set id: 6ab6cf0e-a6c9-4b5a-95c1-37c279bf18dc
Version: 1
Effective Time: 20220818